In October 2025, Poland’s Ministry of Health published a draft regulation that would make HPV vaccination mandatory for children ages 9 to 15, starting with children born in 2018.
The requirement was proposed to take effect January 1, 2027, but as of October 2026, the ministry had not signed the regulation, and it said it could not yet provide a date for finalizing it. Regardless of whether the proposed requirement takes effect, the public conversation around it offers insight into how people understand HPV vaccination and respond to the prospect of making it mandatory.
Poland implemented a national HPV vaccination program in 2023, which called for free and voluntary vaccination for girls and boys ages 12 and 13. The program expanded in September 2024 to include children ages 9 to 14 and to offer vaccination in schools. As of October 2026, an estimated 18 percent of children born between 2006 and 2017 had received at least one dose, compared with a national target of 60 percent by 2028.
Poland already requires children and adolescents to be vaccinated against 12 diseases, including measles and polio, and provides those vaccines free of charge. The draft regulation would add HPV to that list. Parents who refuse a required vaccine can face fines, though enforcement can be lengthy and inconsistent.
What questions and concerns are people raising about the proposed mandate?
Much of the conversation about the HPV mandate focused on the requirement itself, rather than the vaccine. Opposition to mandatory vaccination was the most common response, including from some people who said they support HPV vaccination. The questions and concerns clustered around six themes, which can reveal information needs regardless of whether the person asking them supports vaccination.
Select a theme to explore common questions.
The mandate and parental choice
The most common objection was to the requirement itself. People asked why a vaccine described as safe and effective would need to be mandatory and argued that the decision belongs to parents. Commenters pointed to other European countries where the vaccine is recommended but voluntary. Some interpreted the difference as evidence that Poland’s proposal serves commercial interests.
Sample questions
- If the vaccine is safe and effective, why would it need to be mandatory?
- Why mandate a vaccine for a virus that is not spread through the air?
- Would Poland be the only country to make HPV vaccination mandatory?
- Why not make the vaccine free and voluntary for everyone, not just those ages 9 to 14?
Legal status and refusal
People were unsure whether the mandate had become law and how it would be adopted. Some asked whether it required a vote in parliament or could be blocked by the president, while others believed the constitution prohibits mandatory vaccination. Many asked what would happen if they declined, including how large the fines could be, whether paying a fine would end the obligation, and whether exemptions would be available.
Sample questions
- Is the mandate final, or is it still a draft?
- Does it require a vote in parliament, and can the president block it?
- What would happen if a parent refuses? How large are the fines?
- Would paying a fine end the obligation?
- Is mandatory vaccination allowed under the constitution?
- Would there be exemptions for children with chronic conditions or past vaccine reactions?
Why boys would be included
Some questioned why the proposed mandate would apply to boys as well as girls. The most frequent objection, often expressed sarcastically, was that boys do not have a cervix and therefore can’t get cervical cancer. Some argued that vaccinating girls should be sufficient. This reflects a misunderstanding of how the HPV vaccine protects against cancers that impact both females and males. This view is consistent with how HPV has been represented in Poland, where for many years it was mainly associated with cervical cancer and women’s health. In online conversation, HPV-related cancers in men were rarely mentioned, though a few commenters asked how common they are.
Sample questions
- Why include boys if they cannot get cervical cancer?
- How common are HPV-related cancers in men?
- Wouldn’t vaccinating girls alone be enough to end cervical cancer?
Vaccine safety
The safety concerns raised in this conversation were not new. Claims that the HPV vaccine causes infertility or serious adverse effects have circulated internationally for years. Comments claiming that the vaccine causes infertility were among the most-liked. Commenters also shared older media reports about girls who described symptoms after vaccination and repeated misleading claims that other countries had withdrawn the vaccine.
Sample questions
- What are the side effects of the vaccine, and where can parents read about them?
- Does the vaccine affect fertility?
- Is there long-term safety data on the HPV vaccine?
Need and effectiveness
Many people asked questions about how the vaccine works and whether it is needed at the proposed ages. The most frequent question was why vaccination would start at age 9 for a sexually transmitted infection and whether it would be better to wait. People also asked why vaccination is necessary if most HPV infections clear without treatment and how many HPV types the vaccine covers. Others asked whether the vaccine benefits adults or people who have already been infected. Some suggested abstinence, fidelity, or regular screening as alternatives to vaccination.
Sample questions
- Why vaccinate at age 9, years before sexual activity?
- How long does protection last? Is there a benefit to waiting if protection wanes?
- If most HPV infections clear without treatment, why vaccinate?
- How many HPV types does the vaccine protect against?
- Is vaccination also needed for adults?
- If people have already had HPV, should they get the vaccine?
- Is regular screening enough to prevent cancer?
Access for people who want the vaccine
Compared with the other themes, a smaller group of commenters welcomed the vaccine and asked how to get it. Adults who had paid for vaccination themselves asked why free vaccination was limited to children and young adults. Others wanted to know which vaccine the public program would provide and whether it would be the version that protects against the most HPV types.
Sample questions
- Will the vaccine be free for adults, too?
- Which vaccine will the public program provide?
What the patterns suggest for communicators
Alongside questions about safety and necessity, Poland’s proposal to make HPV vaccination mandatory also raised concerns about the requirement itself and how it would work. These findings offer lessons for communicators in countries considering or introducing HPV vaccine requirements.
Select each one to see the takeaway and how to address it in messaging.
- Explain why a mandate is being proposed. The most common question was about the need for a mandate. Some commenters said they support HPV vaccination or had already vaccinated their children. Because their objection was to the requirement rather than the vaccine, information about vaccine benefits and safety alone is unlikely to address it. Communicators should explain why a requirement is being proposed and what it is intended to achieve.
- Address comparisons with other countries. Commenters repeatedly named Germany, Norway, and the United Kingdom as countries where HPV vaccination is recommended but not required. Communicators should be prepared to explain why their country is considering a different approach, including their vaccination coverage and public health goals.
- Clarify what is proposed and what is already in effect. Commenters expressed confusion about whether the proposed requirement had become law, how it would be approved, and what would happen if parents refused vaccination. Questions about fines and exemptions were also common. Communicators should explain the approval process, who would be covered, what exemptions would apply, and how the requirement would be enforced.
- Explain why HPV vaccination benefits boys. The most frequent question about boys was why they would need a vaccine associated with cervical cancer. HPV also causes cancers of the throat, anus, and penis, but these were rarely mentioned in the conversation. Boys and men can also carry and transmit the virus without knowing it, since there is no routine HPV test for them. Communicators should explain why HPV vaccination benefits boys directly, including protection against cancers that affect men, rather than focusing solely on cervical cancer prevention.
- Answer specific questions about vaccine need and effectiveness. Commenters asked how long protection lasts and whether it would be better to wait if protection wanes. They asked why vaccination is needed if most HPV infections resolve without treatment, how many HPV types the vaccine covers, and whether it benefits someone who has already been infected. Standard messages about safety and cancer prevention do not always address questions at this level of detail. Communicators should prepare clear, plain-language answers to these questions.
- Don’t automatically treat questions as false claims. These questions often appeared in the same threads as false claims about the vaccine. Some commenters who supported the mandate described those expressing doubt as anti-vaccine, without distinguishing questions from false claims. But asking how long protection lasts or why vaccination is needed when most infections clear does not necessarily indicate opposition to vaccination. Dismissing such questions as misinformation risks alienating people who are seeking answers.